Latest & greatest articles for cerebral palsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cerebral palsy

1. Cerebral palsy in under 25s: assessment and management

and developmental follow-up programme (see section 1.3) for children who have any of the risk factors listed in recommendation 1.1.1. Cerebral palsy in under 25s: assessment and management (NG62) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 6 of 461.2 Causes of cerebral palsy 1.2.1 When assessing the likely cause of cerebral palsy in a child, recognise that a number of MRI-identified brain abnormalities have been reported (...) of functional impairment than other causes. 1.2.5 Recognise that the clinical syndrome of neonatal encephalopathy can result from various pathological events, such as a hypoxic–ischaemic brain injury or sepsis, and if there has been more than 1 such event they may interact to damage the developing brain. 1.2.6 When assessing the likely cause of cerebral palsy, recognise that neonatal encephalopathy has been reported at the following approximate prevalences in Cerebral palsy in under 25s: assessment

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

2. Cerebral palsy in adults

, despite having enteral anti-dystonic drug treatment or botulinum toxin type A [5] treatment. Provide information and discuss the procedure, including intrathecal baclofen testing, with the person (and their family or carer, if agreed) as described in recommendations 1.3.13 to 1.3.16. Deep br Deep brain stimulation ain stimulation 1.3.25 If adults with cerebral palsy continue to have severe and painful dystonia, despite having enteral anti-dystonic drug treatment or botulinum toxin type A treatment (...) , consider referring them to a specialised centre with experience in providing deep brain stimulation. See also NICE interventional procedures guidance on deep brain stimulation for tremor and dystonia (excluding Parkinson's diseas). Cerebral palsy in adults (NG119) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 19 of 64T o find out why the committee made the recommendations on neurosurgical treatments to reduce

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

3. Cerebral palsy

of cerebral palsy include: Brain tumour — suggested by acute presentation with headache, other signs and symptoms of raised intracranial pressure (such as early morning vomiting), seizures, and focal neurological deficits, following initially normal development. Dystonia — suggested by onset of muscular deformity after several years of normal development. Presents with sustained periods of muscle contraction and dystonia (movements can be abrupt and violent). Contractures are absent. There may (...) Cerebral palsy Cerebral palsy - NICE CKS Share Cerebral palsy: Summary Cerebral palsy (CP) is an umbrella term for a group of permanent movement and posture disorders that limit activity. The undelying cause is an acquired pathology within the developing brain during the prenatal, neonatal, or early infant period. The impaired movement associated with CP results from centrally-mediated abnormal muscle tone which leads (most commonly) to spasticity. CP can also incorporate disorders of sensation

2019 NICE Clinical Knowledge Summaries

4. Cerebral palsy

, diplegias, cerebral palsies , Little disease, Little's disease Files Rapid Response Reference List Published : January 18, 2017 Follow us: © 2017 Canadian Agency for Drugs and Technologies in Health Get our newsletter: 2017 9. Intrathecal baclofen for treating spasticity in children with cerebral palsy . BACKGROUND: Cerebral palsy is a disorder of movement and posture arising from a non-progressive lesion in the developing brain. Spasticity, a disorder of increased muscle tone, is the most common motor (...) 2018 Summary An umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Most common cause of childhood disability affecting 2.5 per 1000 individuals (...) deformity. Definition Cerebral palsy (CP) is an umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections

2018 Trip Latest and Greatest

5. Cerebral palsy

Cerebral palsy Cerebral palsy - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Cerebral palsy Last reviewed: February 2019 Last updated: February 2019 Summary An umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Most common cause of childhood disability affecting 2.5 per 1000 (...) , and extremity deformity. Definition Cerebral palsy (CP) is an umbrella term referring to a non-progressive disease of the brain originating during the antenatal, neonatal, or early postnatal period when brain neuronal connections are still evolving. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14. http://www.ncbi.nlm.nih.gov/pubmed/17370477?tool=bestpractice.com Secondary effects of spasticity

2019 BMJ Best Practice

7. Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebral palsy, epilepsy and neurodegenerative diseases

Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebral palsy, epilepsy and neurodegenerative diseases 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact 21 July 2016 EMA/555265/2016 Committee (...) Pharmacopoeia or blood pressure bpm beats per minute CE Conformité Européene CEP Certificate of Suitability of the Ph.Eur. CHMP Committee for Medicinal Products for Human Use CHO chinese hamster ovary C max maximum concentration in plasma (or serum) CI confidence interval Cl (total plasma) clearance CMS Concerned Member State CNS central nervous system CoA Certificate of Analysis CP cerebral palsy CRS Chemical Reference Substance (official standard) CSF cerebrospinal fluid CSR clinical study report %CV

2016 European Medicines Agency - EPARs

8. Interventions for Children with Cerebral Palsy: Guidelines

Interventions for Children with Cerebral Palsy: Guidelines Interventions for Children with Cerebral Palsy: Guidelines | CADTH.ca Find the information you need Interventions for Children with Cerebral Palsy: Guidelines Interventions for Children with Cerebral Palsy: Guidelines Published on: January 18, 2017 Project Number: RA0884-000 Product Line: Research Type: Other Diagnostics Report Type: Reference List Result type: Report Question What are the evidence-based guidelines regarding (...) interventions for children with cerebral palsy? Key Message No evidence-based guidelines were identified regarding interventions for children with cerebral palsy. Tags nervous system, pediatrics, cerebral palsy, spastic, diplegia, diplegias, cerebral palsies, Little disease, Little's disease Files Rapid Response Reference List Published : January 18, 2017 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

9. The Effects of Physiotherapy and Rehabilitation Programs Following Botulinum Toxin on Children With Cerebral Palsy

Device Product: No Keywords provided by Kübra Seyhan, Hacettepe University: Physical therapy ICF Botulinum toxin Activity Function Additional relevant MeSH terms: Layout table for MeSH terms Cerebral Palsy Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Nervous System Diseases Botulinum Toxins Acetylcholine Release Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Cholinergic Agents Neurotransmitter Agents Physiological Effects of Drugs (...) The Effects of Physiotherapy and Rehabilitation Programs Following Botulinum Toxin on Children With Cerebral Palsy The Effects of Physiotherapy and Rehabilitation Programs Following Botulinum Toxin on Children With Cerebral Palsy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2018 Clinical Trials

10. Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy

Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review) | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share January 26, 2010 ; 74 (4) Special Article Practice Parameter: Pharmacologic treatment of spasticity (...) in children and adolescents with cerebral palsy (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society M. R. Delgado , D. Hirtz , M. Aisen , S. Ashwal , D. L. Fehlings , J. McLaughlin , L. A. Morrison , M. W. Shrader , A. Tilton , J. Vargus-Adams First published January 25, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181cbcd2f M. R. Delgado D. Hirtz M. Aisen S. Ashwal D. L. Fehlings J

2010 American Academy of Neurology

11. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy. (Abstract)

Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy. To assess the efficacy and safety of botulinum toxin A (BoNT-A) injected in both submandibular and parotid versus only in parotid glands as a treatment for drooling in patients with spastic and dyskinetic cerebral palsy (CP), including an assessment of impact on quality of life (QoL) based on items from the International Classification

2017 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain

12. Cerebral palsy

Cerebral palsy Evidence Maps - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4

2018 Trip Evidence Maps

13. Early Diagnosis for Children with Cerebral Palsy: Clinical Effectiveness and Guidelines

Early Diagnosis for Children with Cerebral Palsy: Clinical Effectiveness and Guidelines Early Diagnosis for Children with Cerebral Palsy: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Early Diagnosis for Children with Cerebral Palsy: Clinical Effectiveness and Guidelines Early Diagnosis for Children with Cerebral Palsy: Clinical Effectiveness and Guidelines Published on: January 10, 2018 Project Number: RB1181-000 Product Line: Research Type: Other Diagnostics (...) Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of early diagnosis in children with cerebral palsy? What are the evidence-based guidelines addressing early diagnosis in children with cerebral palsy? Key Message Five systematic reviews, one with meta-analysis, one randomized controlled trial, and one non-randomized study were identified regarding the clinical effectiveness of early diagnosis in children with cerebral palsy. Tags diagnostic tests

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

14. Stretching and Strength Training for Improved Gait Function in Children With Spastic Cerebral Palsy

, MHSc, Oslo University Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: 519681, 2014/1766-1 First Posted: September 28, 2016 Last Update Posted: December 16, 2016 Last Verified: December 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Additional relevant MeSH terms: Layout table for MeSH terms Cerebral Palsy Muscle Spasticity Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Nervous System Diseases Muscular Diseases Musculoskeletal (...) Stretching and Strength Training for Improved Gait Function in Children With Spastic Cerebral Palsy Stretching and Strength Training for Improved Gait Function in Children With Spastic Cerebral Palsy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2016 Clinical Trials

15. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy. (Abstract)

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy. Cerebral palsy (CP) is the most common cause of physical disabilities in children in high-income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT-A) is considered the first-line treatment for focal spasticity in people with CP.To evaluate the effectiveness and safety of BoNT-A compared to other treatments used in the management of lower limb spasticity

2019 Cochrane

16. Cerebral Palsy

Cerebral Palsy Cerebral Palsy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Cerebral Palsy Cerebral Palsy Aka: Cerebral Palsy From (...) Palsy Brain cancer Routine Left lateral position more comfortable for pelvic Educate about injury risks risk s XI. References Majoewsky (2012) EM:Rap 2(9): 4 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Cerebral Palsy." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Cerebral Palsy (C0007789) Definition (CHV) birth injury of the brain nerve

2018 FP Notebook

17. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Full Text available with Trip Pro

Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Cerebral palsy is an umbrella term that encompasses disorders of movement and posture attributed to non-progressive disturbances occurring in the developing foetal or infant brain. As there are diverse risk factors and aetiologies, no one strategy will prevent cerebral palsy. Therefore, there is a need to systematically consider all potentially relevant interventions for prevention.PrimaryTo (...) summarise the evidence from Cochrane Systematic Reviews regarding effects of neonatal interventions for preventing cerebral palsy (reducing cerebral palsy risk).SecondaryTo summarise the evidence from Cochrane Systematic Reviews regarding effects of neonatal interventions that may increase cerebral palsy risk.We searched the Cochrane Database of Systematic Reviews (27 November 2016) for reviews of neonatal interventions reporting on cerebral palsy. Two review authors assessed reviews for inclusion

2018 Cochrane

18. Management of upper limb dysfunction in children with cerebral palsy: a systematic review

Management of upper limb dysfunction in children with cerebral palsy: a systematic review Management of upper limb dysfunction in children with cerebral palsy: a systematic review Management of upper limb dysfunction in children with cerebral palsy: a systematic review Boyd R N, Morris M E, Graham H K Authors' objectives To evaluate the efficacy of different treatments for the management of upper limb dysfunction in children with cerebral palsy (CP). Searching The following databases were (...) searched: MEDLINE from 1966 to December 2000; CINAHL from 1982 to December 2000; ClinPSYC from 1989 to December 2000; DARE (September 2000); PEDro; EBM Reviews: Best Evidence from 1991 to December 2000; the Cochrane Database of Systematic Reviews (Issue 4, 2000); and the Cochrane Controlled Trials Register (CENTRAL/CCTR). The exploded search terms used were 'cerebral palsy', 'upper limb', 'spasticity', 'physical therapy or physiotherapy', 'occupational therapy', 'neurodevelopmental therapy

2001 DARE.

19. The Effects of Traditional Massage on Spasticity and Activity of Children(2 to 10 Years) With Cerebral Palsy

for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Qamar Mehmood, Isra University: cerebral palsy, traditional massage, spasticity, children Additional relevant MeSH terms: Layout table for MeSH terms Paralysis Cerebral Palsy Muscle Spasticity Neurologic Manifestations Nervous System Diseases Signs and Symptoms Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Muscular Diseases Musculoskeletal (...) The Effects of Traditional Massage on Spasticity and Activity of Children(2 to 10 Years) With Cerebral Palsy The Effects of Traditional Massage on Spasticity and Activity of Children(2 to 10 Years) With Cerebral Palsy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2018 Clinical Trials

20. Periodontal disease in children and young adults with cerebral palsy: a systematic review

Periodontal disease in children and young adults with cerebral palsy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2019 PROSPERO